People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other, Biotechnology, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kill Cliff, Inc. | — | Other | Series A | $29.1M | $13.0M | 2018 |
| Seahorse Bioscience Inc | — | Biotechnology | Series A | $20.7M | $410.2M | 2012 |
| Bam Labs Inc | — | Other Technology | Series A | $17.4M | $97.1M | 2009 |
| Alertsense, Inc. | — | Other | Series A | $5.9M | $88.7M | 2017 |
| Agile Sciences, Inc | — | Pharmaceuticals | Seed | $2.3M | $38.0M | 2020 |
| Lv2Gv Llc | — | Other | Seed | $1.5M | $27.9M | 2018 |
Steven Young at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Young on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Smith | 1 | 42 |
| David Stone | 1 | 12 |
| Chris Irwin | 1 | 10 |
| Zachary Smith | 1 | 10 |
| Fouad Azzam | 1 | 8 |
| John Giannuzzi | 1 | 7 |
| Stephen Hughes | 1 | 6 |
| Harry Wilcox | 1 | 6 |
| Robert Watson | 1 | 6 |
| Paul Nardone | 1 | 5 |
| Joseph Keegan | 1 | 4 |
| David LaVance | 1 | 4 |
| Robert Dobkin | 1 | 3 |
| Jeffrey Hurst | 1 | 2 |
| Blake Hansen | 1 | 2 |
| Joe Driscoll | 1 | 2 |
| Joel Shapiro | 1 | 2 |
| James Friedlander | 1 | 2 |
| Jay Teich | 1 | 2 |
| Keith Stoneback | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.